黄芪注射液对化疗副作用的拮抗作用的临床观察

【目的】观察黄芪注射液在调节化疗后患者免疫功能的作用。【方法】观察34例确诊为急性髓系白血病患者进行2个周期化疗的情况。第1周期予单纯DA方案化疗,第2周期在DA方案化疗的同时,加用黄芪注射液20 mL静滴,1次／d, 连用2周。观察两个周期化疗期间患者的骨髓抑制情况和免疫功能情况。【结果】2个周期化疗后进行对比,第1周期化疗后患者出现明显的骨髓抑制及疲乏、虚汗、食欲减退、精神不振等机体免疫力下降表现;患者外周血免疫球蛋白IgA、IgG、 IgM和补体C3均呈不同程度下降(P<0．01)。第2周期化疗后患者骨髓抑制有所减轻,大多数患者疲乏、虚汗等不适较轻微;外周血免疫球蛋白IgA、IgG、IgM和补体C3含量较第1周期化疗下降程度减少(P<0．05或P<0．01)。【结论】黄芪注射液能减少化疗的毒副作用,增强机体的免疫功能。

Clinical Observation on Huangqi Injection in Inhibiting the Side Effects Induced by Chemotherapy

[Objective] To observe the regulatory effect of Huangqi Injection (HI) on immune function of patients after chemotherapy (CT). [Methods] Thirty-four patients confirmed as acute myelogenous leukemia (AML) received two cycles of CT. During the 1st cycle, the patients were only treated with DA (daunomycin arabinoside) regimen; in the 2nd cycle, intravenous injection of 20 mL of HI, qd for 2 weeks was added. The effect of CT on myelosuppression and immune function of the patients was observed. [Results] Immunosuppressive manifestations such as myelosuppression, fatigue, spontaneous sweating, impaired appetite, lassitude were found after the 1st cycle of CT, and peripheral immunoglobulin A (IgA), IgG, IgM and complements C3 levels were also decreased (P < 0.01 compared with those before CT). After the 2nd cycle of CT, myelosuppression was relieved, discomfort such as fatigue and spontaneous sweating was mild in most of the patients, and the decreased peripheral IgA, IgG, IgM and complements C3 levels was increased (P < 0.05 or P < 0.01 compared with those after the 1st cycle of CT). [Conclusion] HI can relieve the toxic and side effects induced by CT and can enhance the immune function of patients with AML.